These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 34500373

  • 1. LncRNA RP11-116G8.5 promotes the progression of lung squamous cell carcinoma through sponging miR-3150b-3p/miR-6870-5p to upregulate PHF12/FOXP4.
    Li H, Zhao Q, Tang Z.
    Pathol Res Pract; 2021 Oct; 226():153566. PubMed ID: 34500373
    [Abstract] [Full Text] [Related]

  • 2. H3K27ac-activated LINC00519 promotes lung squamous cell carcinoma progression by targeting miR-450b-5p/miR-515-5p/YAP1 axis.
    Ye P, Lv X, Aizemaiti R, Cheng J, Xia P, Di M.
    Cell Prolif; 2020 May; 53(5):e12797. PubMed ID: 32297697
    [Abstract] [Full Text] [Related]

  • 3. LncRNA PITPNA-AS1/miR-223-3p/PTN axis regulates malignant progression and stemness in lung squamous cell carcinoma.
    Peng BH, Ji YF, Qiu XJ.
    J Clin Lab Anal; 2022 Jul; 36(7):e24506. PubMed ID: 35588441
    [Abstract] [Full Text] [Related]

  • 4. LncRNA MIR9-3HG enhances LIMK1 mRNA and protein levels to contribute to the carcinogenesis of lung squamous cell carcinoma via sponging miR-138-5p and recruiting TAF15.
    Xiong Y, Yang C, Yang X, Ding C, Wang Q, Zhu H.
    Pathol Res Pract; 2022 Sep; 237():153941. PubMed ID: 35933883
    [Abstract] [Full Text] [Related]

  • 5. LncRNA RP11-436H11.5, functioning as a competitive endogenous RNA, upregulates BCL-W expression by sponging miR-335-5p and promotes proliferation and invasion in renal cell carcinoma.
    Wang K, Jin W, Song Y, Fei X.
    Mol Cancer; 2017 Oct 25; 16(1):166. PubMed ID: 29070041
    [Abstract] [Full Text] [Related]

  • 6. MIR205HG acts as a ceRNA to expedite cell proliferation and progression in lung squamous cell carcinoma via targeting miR-299-3p/MAP3K2 axis.
    Liu L, Li Y, Zhang R, Li C, Xiong J, Wei Y.
    BMC Pulm Med; 2020 Jun 08; 20(1):163. PubMed ID: 32513149
    [Abstract] [Full Text] [Related]

  • 7. miR-223-5p Suppresses OTX1 to Mediate Malignant Progression of Lung Squamous Cell Carcinoma Cells.
    Lu Y.
    Comput Math Methods Med; 2021 Jun 08; 2021():6248793. PubMed ID: 34306176
    [Abstract] [Full Text] [Related]

  • 8. LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR-433-3p to upregulate WTAP.
    Weng L, Qiu K, Gao W, Shi C, Shu F.
    BMC Pulm Med; 2020 Aug 12; 20(1):213. PubMed ID: 32787827
    [Abstract] [Full Text] [Related]

  • 9. Long noncoding RNA RP11-757G1.5 sponges miR-139-5p and upregulates YAP1 thereby promoting the proliferation and liver, spleen metastasis of colorectal cancer.
    Zhu X, Bu F, Tan T, Luo Q, Zhu J, Lin K, Huang J, Luo C, Zhu Z.
    J Exp Clin Cancer Res; 2020 Oct 06; 39(1):207. PubMed ID: 33023613
    [Abstract] [Full Text] [Related]

  • 10. LINC01232 promotes lung squamous cell carcinoma progression through modulating miR-181a-5p/SMAD2 axis.
    Zhang D, Hua M, Zhang N.
    Am J Med Sci; 2023 Apr 06; 365(4):386-395. PubMed ID: 36543302
    [Abstract] [Full Text] [Related]

  • 11. Identification of a dysregulated ceRNA network modulated by copy number variation-driven lncRNAs in lung squamous cell carcinoma.
    Ding J, Huang M, Huang B, Peng X, Wu G, Peng C, Zhang H, Mao C, Wu X.
    Environ Mol Mutagen; 2022 Aug 06; 63(7):351-361. PubMed ID: 36161731
    [Abstract] [Full Text] [Related]

  • 12. Up-regulation of microRNA-491-5p suppresses cell proliferation and promotes apoptosis by targeting FOXP4 in human osteosarcoma.
    Yin Z, Ding H, He E, Chen J, Li M.
    Cell Prolif; 2017 Feb 06; 50(1):. PubMed ID: 27704627
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression of lncRNA LINC00943 in lung squamous cell carcinoma and its relationship with tumor progression.
    Zhao Z, Li H, Li J, Rong Y, Zhao L, Hao M, Tian F.
    J Cardiothorac Surg; 2024 Apr 16; 19(1):222. PubMed ID: 38627774
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. LncRNA FOXP4-AS promotes the progression of non-small cell lung cancer by regulating the miR-3184-5p/EIF5A axis.
    Li D, Li Z, YanFei W, Wang Y, Shi J, Liu C, Qu L, Deng S, Xiong D.
    J Tissue Eng Regen Med; 2022 Apr 16; 16(4):335-345. PubMed ID: 34921595
    [Abstract] [Full Text] [Related]

  • 17. RP11-295G20.2 facilitates hepatocellular carcinoma progression via the miR-6884-3p/CCNB1 pathway.
    Li J, Xia T, Cao J, He D, Chen Z, Liang B, Song J.
    Aging (Albany NY); 2020 Jul 20; 12(14):14918-14932. PubMed ID: 32687483
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. LncRNA NNT-AS1 promotes lung squamous cell carcinoma progression by regulating the miR-22/FOXM1 axis.
    Ma J, Qi G, Li L.
    Cell Mol Biol Lett; 2020 Jul 20; 25():34. PubMed ID: 32514270
    [Abstract] [Full Text] [Related]

  • 20. LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer.
    Luo W, Wang J, Xu W, Ma C, Wan F, Huang Y, Yao M, Zhang H, Qu Y, Ye D, Zhu Y.
    Cell Death Dis; 2021 Nov 02; 12(11):1043. PubMed ID: 34728613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.